Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study

被引：0

作者：

Ibrar Ahmed

Umar Yousaf Raja

Muhammad Umar Wahab

Tejhmal Rehman

Osama Ishtiaq

A. H. Aamir

Tahir Ghaffar

Abbas Raza

Suresh Kumar

Akhtar Sherin

Faisal Masood

Fawad Ahmad Randhawa

Ali Asghar

Sehrish Khan

机构：

[1] Lady Reading Hospital,Umer Diabetes and Foot Clinic

[2] Soekarno Rd,Shaukat Khanum Hospital

[3] PTCL Colony,undefined

[4] Peshawar,undefined

[5] Shifa International,undefined

[6] Malak shafait plaza,undefined

[7] Mauza Mahal kot,undefined

[8] Hayatabad Medical Complex,undefined

[9] 153-E,undefined

[10] Shah Noor Park (adjacent Clinix Pharmacy Head Office),undefined

[11] Bolan Medical,undefined

[12] KMU Institute of Medical Sciences,undefined

[13] KIMS,undefined

[14] Alkhaliq Hospital,undefined

[15] Mayo Hospital,undefined

[16] Hospital Rd,undefined

[17] Liaquat National Hospital,undefined

[18] National Stadium Rd,undefined

[19] Liaquat National Hospital,undefined

来源：

BMC Endocrine Disorders | / 22卷

关键词：

Diabetes; Ramadan; Fasting; Hypoglycemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
Williams-Herman, D.
Johnson, J.
Teng, R.
Golm, G.
Kaufman, K. D.
Goldstein, B. J.
Amatruda, J. M.
DIABETES OBESITY & METABOLISM, 2010, 12 (05): : 442 - 451
[32] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin
Andrea D. Fass
Jennifer A. Gershman
Advances in Therapy, 2013, 30 : 337 - 353
[33] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin
Fass, Andrea D.
Gershman, Jennifer A.
ADVANCES IN THERAPY, 2013, 30 (04) : 337 - 353
[34] Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC study
Lim, Soo
An, Jee Hyun
Shin, Hayley
Khang, Ah Reum
Lee, Yenna
Ahn, Hwa Young
Yoon, Ji Won
Kang, Seon Mee
Choi, Sung Hee
Cho, Young Min
Park, Kyong Soo
Jang, Hak Chul
CLINICAL ENDOCRINOLOGY, 2012, 77 (02) : 215 - 223
[35] Efficacy and safety of empagliflozin as an add on to metformin and DPP4 inhibitor in T2DM patients, fasting during Ramadan
Pathan, M. F.
Akter, N.
Selim, S.
Saifuddin, M.
Qureshi, N. K.
Hasan, A. B. M. K.
Hannan, M. A.
Ahmed, M. A. U.
Mustari, M.
Chakraborty, A. K.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
[36] SITAGLIPTIN AND METFORMIN ALONE OR IN COMBINATION IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME (PCOS): A PILOT STUDY
Paredes-Palma, J. C.
Lopez-Bayghen, E.
FERTILITY AND STERILITY, 2014, 102 (03) : E266 - E266
[37] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes
Perez-Monteverde, A.
Seck, T.
Xu, L.
Lee, M. A.
Sisk, C. M.
Williams-Herman, D. E.
Engel, S. S.
Kaufman, K. D.
Goldstein, B. J.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 930 - 938
[38] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
Kim, Kyoung Min
Lee, Seo Young
Lee, Ji Hyun
Lee, Dong Hwa
Oh, Tae Jung
Jang, Hak Chul
Lim, Soo
DIABETES, 2017, 66 : A346 - A346
[39] Efficacy and safety of the glucagon receptor antagonist, MK-0893, in combination with metformin or sitagliptin in patients with type 2 diabetes mellitus
Engel, S. S.
Teng, R.
Edwards, R. J.
Davies, M. J.
Kaufman, K. D.
Goldstein, B. J.
DIABETOLOGIA, 2011, 54 : S86 - S87
[40] Efficacy and safety of linagliptin and metformin combination compared with metformin alone on stratified approach of type 2 diabetes treatment
Shi, Y.
Walt, S. V. D.
Miao, L.
DIABETOLOGIA, 2018, 61 : S378 - S378

← 1 2 3 4 5 →